Skip to content
SPACListing
CompletedNasdaq

biote Corp.BTMD

Class A BTMDCIK 0001819253

Cash in trust

$318M

$317,582,318

Trust per share

$10.21

Redemption value

IPO

Mar 2021

$311M raised

Combination deadline

—

Not disclosed

Filings on record

410

Latest Sep 18, 2026

Business combination

Target
Not disclosed in an indexed filing
Announced
Feb 11, 2022
Closed
Jun 2, 2022

Overview

biote Corp. is a special purpose acquisition company incorporated and registered with the SEC under CIK 0001819253. It completed its initial public offering in Mar 2021, raising $311M in gross proceeds and listing on Nasdaq. Class A shares trade under the ticker BTMD on Nasdaq. The vehicle is sponsored by Haymaker through Haymaker Sponsor III LLC. The mandate targets consumer. Business combination closed; the company trades under a new ticker.

“We intend to acquire and operate a business in the consumer and consumer-related products and services industries and believe our management team is well suited to identify opportunities that have the potential to generate attractive risk-adjusted returns for our stockholders.”
The mandate, as stated in the IPO prospectus

Reading the filings

Arithmetic on what biote Corp. has disclosed, written the way a desk would read it. These are observations, not a rating. Nothing here scores the vehicle or implies a view on it.

  • Trust versus the $10 unit

    The trust holds $10.21 per public share, 2.1% above the $10.00 the units were sold at. That spread is accrued interest on the trust and, where the charter provides for it, sponsor contributions paid in to buy more time. It is the floor a public shareholder can redeem at, not a valuation of the business.

  • Warrant coverage

    Each unit carried one-fourth warrant per unit. Warrants are dilution deferred: they cost the holder nothing until exercised, and they overhang the post-combination share count. Thinner coverage is generally a sign of a stronger book at pricing.

  • Sponsor record

    Haymaker has launched 5 vehicles. Of the 4 that have resolved, 4 closed a combination and 0 liquidated, a 100% completion rate. A sponsor's record is not a forecast, but it does tell you whether the team has taken a deal across the line before.

  • Underwriting

    Citigroup led the offering. It has been named on 170 SPAC IPOs, book-running 114 of them, and 53.6% of its resolved vehicles closed a deal. The syndicate has no control over whether a sponsor finds a target, but the quality of the book at pricing shapes who ends up holding the units.

How busy it has been

Filings per month since the first one. A vehicle that has gone quiet with a deadline ahead is a different proposition from one that is still working.

241202020-082026-09

410 filings in all. 7 in the last three months, against a busiest month of 24.

News on biote Corp.

Last 90 days

News sentiment

Neutral
negativeneutralpositive

Across 1 recent story, weighted towards the newest. Scored by our own headline classifier using finance- and SPAC-specific terms. It reads what a story is about, not what the shares are worth.

SEC filing history

Free tier: filings older than 24 hours
  • SCHEDULE 13G/A

    Amended beneficial ownership report (passive)

    Accession 0001820959-26-000001

    Sep 18, 2026

    1mo ago

    View on EDGAR ↗
  • SCHEDULE 13G/A

    Amended beneficial ownership report (passive)

    Accession 0001493152-26-041060

    Sep 1, 2026

    1mo ago

    View on EDGAR ↗
  • SCHEDULE 13G

    Beneficial ownership report (passive)

    Accession 0001493152-26-040561

    Aug 28, 2026

    2mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0001314575-26-000007

    Aug 12, 2026

    2mo ago

    View on EDGAR ↗
  • 10-Q

    Quarterly report

    Accession 0001193125-26-340364

    Aug 7, 2026

    2mo ago

    View on EDGAR ↗
  • 8-K

    Current report

    Items 2.02, 9.01 · Accession 0001193125-26-335200

    Aug 5, 2026

    2mo ago

    View on EDGAR ↗
  • SCHEDULE 13G/A

    Amended beneficial ownership report (passive)

    Accession 0002012383-26-002270

    Jul 27, 2026

    3mo ago

    View on EDGAR ↗
  • 8-K/A

    8-K/A

    Item 5.02 · Accession 0001193125-26-274137

    Jun 17, 2026

    4mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0002005188-26-000004

    Jun 16, 2026

    4mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0001707443-26-000004

    Jun 10, 2026

    4mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0001314575-26-000004

    Jun 10, 2026

    4mo ago

    View on EDGAR ↗
  • 8-K

    Regulation FD disclosure

    Items 5.02, 7.01, 9.01 · Accession 0001193125-26-253858

    Jun 2, 2026

    5mo ago

    View on EDGAR ↗
  • 8-K

    Submission of matters to a vote of security holders

    Item 5.07 · Accession 0001193125-26-229013

    May 18, 2026

    5mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0001259062-26-000002

    May 14, 2026

    5mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0001838995-26-000001

    May 13, 2026

    5mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0001931328-26-000002

    May 13, 2026

    5mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0001931319-26-000002

    May 13, 2026

    5mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0001314575-26-000002

    May 13, 2026

    5mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0001773204-26-000002

    May 13, 2026

    5mo ago

    View on EDGAR ↗
  • SCHEDULE 13G/A

    Amended beneficial ownership report (passive)

    Accession 0000921895-26-001270

    May 13, 2026

    5mo ago

    View on EDGAR ↗
  • 10-Q

    Quarterly report

    Accession 0001193125-26-216780

    May 11, 2026

    5mo ago

    View on EDGAR ↗
  • 8-K

    Current report

    Items 2.02, 9.01 · Accession 0001193125-26-208965

    May 6, 2026

    5mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0002125693-26-000005

    May 4, 2026

    5mo ago

    View on EDGAR ↗
  • 3

    Initial statement of beneficial ownership

    Accession 0002125693-26-000004

    May 4, 2026

    5mo ago

    View on EDGAR ↗
  • S-8

    S-8

    Accession 0001193125-26-155037

    Apr 14, 2026

    6mo ago

    View on EDGAR ↗
  • 8-K

    Regulation FD disclosure

    Items 7.01, 9.01 · Accession 0001193125-26-142147

    Apr 3, 2026

    7mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0001707443-26-000002

    Apr 3, 2026

    7mo ago

    View on EDGAR ↗
  • 4

    Statement of changes in beneficial ownership

    Accession 0002005188-26-000002

    Apr 3, 2026

    7mo ago

    View on EDGAR ↗
  • ARS

    ARS

    Accession 0001193125-26-140116

    Apr 2, 2026

    7mo ago

    View on EDGAR ↗
  • DEFA14A

    Additional proxy soliciting material

    Accession 0001193125-26-140105

    Apr 2, 2026

    7mo ago

    View on EDGAR ↗

Pro

Track BTMD without the delay

Free accounts see this filing history a day late. Pro shows every document minutes after EDGAR publishes it, opens it on EDGAR in one click, and adds the twelve-month deadline calendar.

  • Filings live, no 24-hour delay
  • One click through to the source document
  • Deadline calendar out to 12 months
  • CSV export, API and MCP access

Cancel any time. Billed monthly in USD.

biote Corp.: questions answered

What is biote Corp. (BTMD)?

biote Corp. is a special purpose acquisition company incorporated and registered with the SEC under CIK 0001819253. It completed its initial public offering in Mar 2021, raising $311M in gross proceeds and listing on Nasdaq. Class A shares trade under the ticker BTMD on Nasdaq. The vehicle is sponsored by Haymaker through Haymaker Sponsor III LLC. The mandate targets consumer. Business combination closed; the company trades under a new ticker.

How much does biote Corp. hold in trust?

Approximately $317,582,318, or about $10.21 per public share, as at the most recent filing on record. Trust balances move: shareholders redeem at extension votes and at the combination vote, and sponsors pay contributions in to extend. Treat the figure as a point-in-time disclosure, not a running balance.

When must biote Corp. complete a merger?

No combination deadline appears in the filings we have indexed. The date is stated in the charter and repeated in each quarterly report; where our parser could not establish it with confidence we leave it blank rather than infer one.

What happens if biote Corp. does not find a target in time?

The charter requires the vehicle to redeem 100% of the public shares and return the trust, pro rata, to public shareholders. That is the mechanism working as designed rather than a default. Founder shares and warrants are worthless in that outcome, which is why the sponsor's incentive is to get a deal done or to buy more time. Across the market, deadline lapsed without a deal; trust returned to public shareholders.

Can I redeem shares in biote Corp., and at what price?

Public shareholders may elect to redeem in connection with a combination vote and at each extension vote, at the pro-rata trust value on the relevant record date, most recently disclosed at about $10.21 per share. Redemption is a right attached to the public shares only; warrants and rights carry no claim on the trust. The mechanics and the deadline for electing are set out in the proxy statement for the vote in question.

What tickers does biote Corp. trade under?

Class A shares trade as BTMD on Nasdaq. Units trade first and separate into their component securities roughly 52 days after the IPO; only the Class A shares carry the redemption right against the trust.

Is the trust value the same as the share price for biote Corp.?

No, and the gap between them is the whole trade. Trust per share is a disclosed, contractual figure of $10.21, being what a redeeming holder receives. The market price is whatever the shares change hands at: most recently $1.11, a spread to the redemption value. Quotes on this site are delayed and indicative; confirm on your own venue before trading.

How much dilution do biote Corp.'s founder shares and warrants create?

Each unit also carried one-fourth warrant per unit, which is dilution deferred until exercise. Both are disclosed in the prospectus and both survive into the combined company, which is why a de-SPAC at $10 is not economically the same as an IPO at $10.

Who sponsors biote Corp., and what is their track record?

Haymaker Sponsor III LLC is the sponsor entity, part of the Haymaker franchise. That franchise has launched 5 vehicles in total, of which 4 closed a combination and 0 liquidated, a 100% completion rate on resolved vehicles. Named principals: Andrew R. Heyer, Steven J. Heyer.

Which banks underwrote the biote Corp. IPO?

Citigroup, Cantor Fitzgerald. Syndicate membership and role are read from the prospectus cover and the underwriting section.

Is biote Corp. tradeable, and where?

Yes. BTMD returned a live quote of $1.11 on Nasdaq. Quotes here are delayed and refreshed on a schedule rather than streamed, so treat the figure as indicative and confirm on your own venue. Units and warrants trade under their own symbols and are quoted separately.

Is biote Corp. a good investment?

That is not a question this site answers. biote Corp. is covered here as reference data: what the company filed, when it filed it, and what the numbers in those filings say. The Edge, FOMO and Potential scores on this page are derived measures with a published formula, not ratings of investment merit: they describe the setup, and every component is shown so you can take them apart. We publish no price targets and no recommendations, and nothing here should be read as advice. The figures are a starting point for your own work, and each one carries the accession number of the filing it came from.

Where does this biote Corp. data come from?

Filings biote Corp. submitted to the SEC under CIK 0001819253: the registration statement and final prospectus for the structure, quarterly and annual reports for the trust, current reports and proxy statements for deals, votes and extensions. Trust economics are taken from the registrant's own XBRL tags rather than parsed from prose, which is why they are exact. Every filing in the history above is listed with its accession number, which identifies the document uniquely on EDGAR; Pro accounts open it directly from the row.

Compiled by the SPACListing research desk

Last reconciled Oct 31, 2026

Every figure on this page is read from documents the registrants filed with the U.S. Securities and Exchange Commission, principally the IPO prospectus (Form 424B4), quarterly and annual reports, current reports and proxy statements, the registrant's own XBRL tags for trust economics. Nothing is sourced from press coverage, from the companies themselves, or from a third-party aggregator. Where a filing does not disclose something, the field is left blank rather than estimated.

Read the full methodology · What is in the dataset · Report a correction

SPACListing is a reference-data service, not an investment adviser. Nothing here is a recommendation to buy or sell any security.

Continue reading

The context around this vehicle: who else the sponsor has launched, which banks priced it, and where it sits in the wider market.